URICOSURIC ACTION OF HALOFENATE (MK-185) IN PATIENTS WITH HYPERURICEMIA OR UNCOMPLICATED PRIMARY GOUT AND HYPERLIPIDEMIA

被引：14
|
作者：
HUTCHISON, JC [1 ]
WILKINSON, WH [1 ]
机构：
[1] ABINGTON MEM HOSP, ABINGTON, PA 19001 USA
来源：
ATHEROSCLEROSIS | 1973年 / 18卷 / 03期
关键词：
D O I：
10.1016/0021-9150(73)90065-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：353 / 362
页数：10
相关论文
共 12 条
  • [1] HYPOLIPIDEMIC, URICOSURIC, AND THYROXINE-DISPLACING EFFECTS OF MK-185 (HALOFENATE)
    MORGAN, JP
    BIANCHINE, JR
    HSU, TH
    MARGOLIS, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1971, 12 (03) : 517 - +
  • [2] COMPARISON OF EFFECTS OF CLOFIBRATE AND HALOFENATE (MK-185) IN ISOLATED RAT HEPATOCYTES
    HOMCY, CJ
    MARGOLIS, S
    ATHEROSCLEROSIS, 1974, 19 (03) : 381 - 391
  • [3] COMPARISON OF EFFECTS OF HALOFENATE (MK-185) AND CLOFIBRATE ON PLASMA LIPID AND URIC-ACID CONCENTRATION IN HYPERLIPOPROTEINEMIC PATIENTS
    LISCH, HJ
    PATSCH, J
    SAILER, S
    BRAUNSTEINER, H
    ATHEROSCLEROSIS, 1975, 21 (03) : 391 - 399
  • [4] ANOMALOUS RESULTS OF STUDIES ON DRUG INTERACTION IN MAN .2. HALOFENATE (MK-185) AND ANTIPYRINE, BISHYDROXYCOUMARIN, AND WARFARIN
    VESELL, ES
    PASSANANTI, GT
    PHARMACOLOGY, 1975, 13 (02) : 112 - 127
  • [5] Risk Factors Associated With Renal Lithiasis During Uricosuric Treatment of Hyperuricemia in Patients With Gout
    Perez-Ruiz, Fernando
    Hernandez-Baldizon, Samuel
    Herrero-Beites, Ana M.
    Gonzalez-Gay, Miguel A.
    ARTHRITIS CARE & RESEARCH, 2010, 62 (09) : 1299 - 1305
  • [6] URAT1 gene polymorphisms influence uricosuric action of losartan in hypertensive patients with hyperuricemia
    Sun, Hong
    Qu, Qiang
    Qu, Jian
    Lou, Xiao-Ya
    Peng, Yan
    Zeng, Ying
    Wang, Guo
    PHARMACOGENOMICS, 2015, 16 (08) : 855 - 863
  • [7] How Are We Managing Patients with Hyperuricemia and Gout: A Cross Sectional Study Assessing Knowledge and Attitudes of Primary Care Physicians?
    Furlan, Sanja Zuzic
    Rusic, Doris
    Bozic, Josko
    Rumboldt, Mirjana
    Rumboldt, Zvonko
    Rada, Marko
    Tomicic, Marion
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (03) : 1 - 11
  • [8] TMX-67, a novel xanthine oxidase/xanthine dehydrogenase (XOD) inhibitor, shows strong uric acid lowering action in patients with hyperuricemia and gout.
    Ishiwata, Y
    Kubo, J
    Komoriya, K
    Yamanaka, H
    Kamatani, N
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S129 - S129
  • [9] Efficacy and Safety Following Cessation of Treatment With Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib (MK-0859) in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia
    Bloomfield, Daniel
    Gibbons, Patti
    Liu, Sherry
    Sisk, Christine
    Tribble, Diane
    McKenney, James
    Littlejohn, Thomas, III
    Mitchel, Yale
    CIRCULATION, 2009, 120 (18) : S468 - S468
  • [10] Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia
    Dansky, Hayes M.
    Bloomfield, Daniel
    Gibbons, Patrice
    Liu, Sherry
    Sisk, Christine McCrary
    Tribble, Diane
    McKenney, James M.
    Littlejohn, Thomas W., III
    Mitchel, Yale
    AMERICAN HEART JOURNAL, 2011, 162 (04) : 708 - 716
12